Hjem › Hjertesvikt › Texas › Houston
Kliniske studier for Hjertesvikt i Houston, TX
36 studier for Hjertesvikt søker deltakere på steder i og rundt Houston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
RekruttererFase 3
- Research Site, Houston
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
RekruttererFase 3
- The Methodist Hospital Research Institute, Houston
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
RekruttererFase 2
- East Texas Cardiology PA, Houston
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
RekruttererFase 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Humble · 17 mi unna
BiVACOR® Total Artificial Heart Early Feasibility Study
Rekrutterer
- Texas Heart Institute / Baylor St. Luke's Medical Center, Houston
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
RekruttererFase 3
- CHI St. Luke's Health Baylor College of Medicine Medical Center, Houston
A Study of LY3971297 in Participants With Heart Failure
RekruttererFase 1
- Houston Methodist Hospital, Houston
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RekruttererFase 3
- East Texas Cardiology PA, Houston
- Biopharma Informatic, Houston
- Orion Medical, Houston
- og 3 flere
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
RekruttererFase 3
- Research Site, Houston
- Research Site, Houston
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
RekruttererFase 3
- CON-10085, Houston, TX, Houston
- Houston, TX Investigative Site CON-10320, Houston
Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation
RekruttererObservasjonsstudie
- Methodist DeBakey Heart and Vascular Center, Houston
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RekruttererFase 3
- Houston, TX Investigative Site 10085, Houston
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Rekrutterer
- Houston Methodist Hospital, Houston
- Memorial Hermann-Texas Medical Center, Houston
- Texas Heart Institute at Baylor St. Luke's Medical Center, Houston
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
RekruttererFase 2
- Local Institution - 151, Houston
- Local Institution - 157, Houston
- Local Institution - 163, Houston
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
RekruttererFase 2/3
- Texas Children's Hospital ( Site 0039), Houston
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
RekruttererFase 2
- Center for Advanced Heart Failure, Houston
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
RekruttererObservasjonsstudie
- Texas Children's Hospital, Houston
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Rekrutterer
- Texas Heart Institute, Houston
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RekruttererObservasjonsstudie
- Houston, Houston
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
RekruttererObservasjonsstudie
- The Methodist Hospital, Methodist Cancer Cencer, Houston
- BI Research Center, Houston
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
RekruttererFase 3
- Tenax Investigational Site, Houston
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RekruttererFase 3
- East Texas Cardiology PA, Houston
- Victorium Clinical Research, Houston
- Main Heart Clinic, Houston
- og 1 flere
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Rekrutterer
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Assessment of CCM in HF With Higher Ejection Fraction
Rekrutterer
- Baylor College of Medicine, Houston
- Houston Methodist, Houston
- Memorial Hermann Texas Medical Center, Houston
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
RekruttererFase 3
- FIN-10085, Houston, TX, Houston
18F-mFBG Imaging for Myocardial Sympathetic Innervation
RekruttererFase 2
- UT Health Houston, Houston
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
RekruttererFase 3
- Texas Children's Hospital - Cardiology, Houston
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Rekrutterer
- Baylor/Texas Heart, Houston
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
RekruttererFase 3
- Texas Children's Hospital - Cardiology, Houston
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Rekrutterer
- CHI St. Luke's Health Baylor College of Medicine Medical Center, Houston
- Houston Methodist, Houston
- UTHealth Memorial Hermann, Houston
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
RekruttererObservasjonsstudie
- Baylor College of Medicine, Houston
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Rekrutterer
- Houston Healthcare Medical Center, Houston
Left vs Left Randomized Clinical Trial
Rekrutterer
- Baylor College of Medicine, Houston
Cardiogenic Shock Working Group Registry
RekruttererObservasjonsstudie
- Houston Methodist Hospital, Houston
Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure
RekruttererFase 1
- Texas Heart Institute, Houston
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
RekruttererObservasjonsstudie
- Houston Methodist DeBakey Heart and Vascular Center, Houston
Hjertesvikt-studier i andre byer
- New York City, NY51 studier
- Boston, MA44 studier
- Dallas, TX42 studier
- Cleveland, OH33 studier
- Chicago, IL31 studier
- Philadelphia, PA31 studier
- San Francisco, CA29 studier
- St. Louis, MO26 studier
- Durham, NC26 studier
- Kansas City, MO25 studier
- Atlanta, GA25 studier
- Baltimore, MD24 studier
Andre studier i Houston
- Ikke-småcellet lungekreft145 studier
- Brystkreft126 studier
- Kreft (alle typer)121 studier
- Metastatisk kreft104 studier
- Kolorektal kreft102 studier
- Eggstokkreft89 studier
- Akut myelogen leukemi85 studier
- Lungekreft78 studier
- Prostatakreft76 studier
- Endometriekreft68 studier
- Pankreaskreft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.